Home
Finance
Companies
Industry
Market

NASDAQ:LEXX

Lexaria Bioscience Corp [LEXX] is -51.58% lower this YTD. Is it still time to buy?

September 26, 2025

Edison Baldwin

Lexaria Bioscience Corp [NASDAQ: LEXX] stock went on an upward path that rose over 7.75% on Thursday, amounting to a ...

most recent

Finance

Wall Street Analyst Initiated GSR III Acquisition Corp [GSRT]. What else is Wall St. saying

Companies

Morgan Stanley slashes price target on Grocery Outlet Holding Corp [GO] – find out why.

Market

Maxim Group lifts Gold Royalty Corp [GROY] price estimate. Who else is bullish?

Industry

Guardant Health Inc [GH] stock Upgrade by Wolfe Research analyst, price target now $75

Finance

Lexaria Bioscience Corp [LEXX] is -51.58% lower this YTD. Is it still time to buy?

Companies

For Edwards Lifesciences Corp [EW], Analyst sees a rise to $100. What next?

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled